• Reproductive and Developmental Biology
• /
• 제35권4호
• /
• pp.427-434
• /
• 2011

Mitochondria diseases have been reported to involve structural and functional defects of complex I-V. Especially, many of these diseases are known to be related to dysfunction of mitochondrial proton-translocating NADH-ubiquinone oxidoreductase (complex I). The dysfunction of mitochondria complex I is associated with neurodegenerative disorders, such as Parkinson's disease, Huntington's disease, and Leber's hereditary optic neuropathy (LHON). Mammalian mitochondrial proton-translocating NADH-quinone oxidoreductase (complex I) is largest and consists of at least 46 different subunits. In contrast, the NDI1 gene of Saccharomyces cerevisiae is a single subunit rotenone-insensitive NADH-quinone oxidoreductase that is located on the matrix side of the inner mitochondrial membrane. The Saccharomyces cerevisiae NDI1 gene using a recombinant adeno-associated virus vector (rAAV-NDI1) was successfully expressed in AML12 mouse liver hepatocytes and the NDI1-transduced cells were able to grow in media containing rotenone. In contrast, control cells that did not receive the NDI1 gene failed to survive. The expressed Ndi1 enzyme was recognized to be localized in mitochondria by confocal immunofluorescence microscopic analyses and immunoblotting. Using digitonin-permeabilized cells, it was shown that the NADH oxidase activity of the NDI1-transduced cells was not affected by rotenone which is inhibitor of complex I, but was inhibited by antimycin A. Furthermore, these results indicate that Ndi1 can be functionally expressed in the AML12 mouse liver hepatocytes. It is conceivable that the NDI1 gene is powerful tool for gene therapy of mitochondrial diseases caused by complex I deficiency. In the future, we will attempt to functionally express the NDI1 gene in mouse embryonic stem (mES) cell.

• Korean Journal of Acupuncture
• /
• 제36권4호
• /
• pp.200-209
• /
• 2019

Objectives : The liver is rich in mitochondria and it plays a key role in whole-body energy homeostasis. Mitochondria is double membrane-bound organelle that supplies energy for intracellular metabolism including Krebs cycle and beta-oxidation. Acupuncture is known to stimulate and regulate the flow of energy. To explore the effect of acupuncture on the mitochondrial respiratory chain activity in the rats' livers, the activity of mitochondrial respiratory chain complexes I to IV was observed. Methods : The rats were divided into 4 groups; Normal 1 (no acupuncture treatment and anesthesia for 5 min), Normal 2 (no acupuncture treatment and anesthesia for 10 min), MA1 (acupuncture treatment at bilateral LR3 under anesthesia for 5 min), and MA2 (acupuncture treatment at bilateral LR3 under anesthesia for 10 min). All rats were sacrificed and the livers were examined for respiratory chain change. Results : There was no difference in ubiquinon oxidoreductase, succinate dehydrogenase, and ubiquinol cytochrome C oxidoreductase after acupuncture at LR3. Acupuncture at LR3 for 10 min increased the activity of cytochrome C oxidase compared with no acupuncture groups. Conclusions : Acupuncture at LR3 mediated mitochondrial respiratory chain activity via the cytochrome C oxidase signaling pathway in the livers of rats.

• 생명과학회지
• /
• 제24권1호
• /
• pp.98-103
• /
• 2014

NQO1은 플라보 단백질 계통의 2 전자 환원 효소이며 NADH 또는 NADPH를 보조인자로 quinone 계통의 화합물을 hydroquinone으로 환원 한다. 암에서 NQO1은 그에 상응하는 정상 조직과 비교하였을 때 비교적 높은 발현을 나타낸다. NQO1의 다양한 기능 중 quinone 물질 대사는 두 가지 형태의 상반되는 기능을 가진다. 이것은 quinone으로부터 전환된 hydroquinone의 상태적 안정성과 불안정성에 기인하며, 불안정한 hydroquinone의 생성은 산화적 손상 야기 및 DNA 손상은 세포의 운명을 바꾸어 놓게 된다. 따라서 암에서 그 발현이 높은 NQO1을 표적으로 작용하는 생체환원 물질은 암 세포 사멸을 강하게 유도하게 되어 암 치료의 가능성을 보여주고 있다. 항암 표적 분자로서 NQO1 특징과 NQO1을 통해 작용하는 생체환원물질 ${\beta}$-lapachone의 항암 효과와 기전에 대하여 살펴보았다.

• Archives of Pharmacal Research
• /
• 제23권6호
• /
• pp.554-558
• /
• 2000

Synthesized 5-arylamino-2-methyl-4,7-dioxobenzothiazoles 3a-3o were evaluated for modulation of NAD(P)H: quinone oxidoreductase (NQOl) activity with the cytosolic fractions derived from cultured human lung cancer cells and their cytotoxicity in cultured several human solid cancer cell lines. The 4,7-dioxobenzothiazoles affected the reduction potential by NQOl activity and showed a potent cytotoxic activity against human cancer cell lines. The tested compounds 3a, 3b, 3g, 3h, 3n and 3o were considered as more potent cytotoxic agents, and comparable modulators of NQOl activity.

• Archives of Pharmacal Research
• /
• 제24권5호
• /
• pp.390-396
• /
• 2001

Synthesized 6-arylamino-5,8-quinolinediones 4a-4j and 6-chloro-7-arylamino-5,8-isoquinolinediones 5a-5g were evaluated for effects on NAD(P)H quinone oxidoreductase (NQOl ) activity with the cytosolic fractions derived from cultured human lung cancer cells and their cytotoxicity in cultured several human solid cancer cell lines. The 5,8-quinolinediones 4 and 5,8-isoquinolinediones 5 affected the reduction potential by NQO1 activity and showed a potent cytotoxic activity against human cancer cell lines. The tested compounds 4a, 5c, 5f, and 5g were considered as more potent cytotoxic agents. The compounds 4d, 5b, 5c, 5e and 5g were comparable modulators of NQO1 activity.

• Bulletin of the Korean Chemical Society
• /
• 제33권8호
• /
• pp.2756-2758
• /
• 2012

• Bulletin of the Korean Chemical Society
• /
• 제34권6호
• /
• pp.1621-1622
• /
• 2013

• Bulletin of the Korean Chemical Society
• /
• 제35권6호
• /
• pp.1603-1604
• /
• 2014

• 한국생명과학회:학술대회논문집
• /
• 한국생명과학회 2002년도 제37회 국제학술심포지움 및 추계학술대회
• /
• pp.90-90
• /
• 2002

• 한국생명과학회:학술대회논문집
• /
• 한국생명과학회 2000년도 제29회 국제학술심포지움 및 추계학술대회
• /
• pp.43-43
• /
• 2000